Polar Pharma India Ltd. - Research Center
523333 POLARPH Group (T) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 12 | Mar ' 12 | Sep ' 11 | Mar ' 11 | Sep ' 10 | |
|---|---|---|---|---|---|
| Sales | 0.01 | 9.49 | 6.77 | 10.81 | 0.05 |
| Operating profit | -2.43 | 0.29 | -1.17 | 2.35 | -0.65 |
| Interest | 8.13 | 7.92 | 7.15 | 6.94 | 6.32 |
| Gross profit | -10.56 | -7.55 | -8.32 | -4.50 | -6.97 |
| EPS (Rs) | -9.53 | -7.07 | -7.70 | -4.57 | -6.60 |
Half yearly
results in details
| Sep ' 12 | Mar ' 12 | Sep ' 11 | Mar ' 11 | Sep ' 10 | |
|---|---|---|---|---|---|
| Other income | - | 0.09 | - | 0.09 | - |
| Stock adjustment | -0.05 | 0.41 | 1.32 | -2.06 | - |
| Raw material | 0.09 | 3.61 | 3.20 | 5.66 | - |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 1.47 | 1.58 | 1.49 | 1.34 | 0.27 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 0.93 | 3.61 | 1.93 | 3.52 | 0.42 |
| Provisions made | - | - | - | - | - |
| Depreciation | 1.12 | 1.13 | 1.13 | 1.10 | 1.13 |
| Taxation | - | - | - | - | - |
| Net profit / loss | -11.69 | -8.67 | -9.45 | -5.61 | -8.10 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 12.27 | 12.27 | 12.27 | 12.27 | 12.27 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | 86.21 | 86.21 | 86.21 | 86.21 | 86.21 |
| Agg.of non promotoholding (%) | 70.25 | 70.25 | 70.25 | 70.25 | 70.25 |
| OPM (%) | -41213.56 | 3.03 | -17.21 | 21.75 | -1409.57 |
| GPM (%) | -162529.23 | -78.78 | - | -41.34 | - |
| NPM (%) | -179835.38 | -90.56 | - | -51.44 | - |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis